146 related articles for article (PubMed ID: 37254642)
1. Establishment and characterization of two novel patient-derived lines from canine high-grade glioma.
Schrock MS; Zalenski AA; Tallman MM; Kollin L; Bratasz A; Weeks G; Miller MA; Sweeney CN; Pluhar GE; Olin MR; Kisseberth WC; Bentley RT; Dickinson PJ; York D; Webb A; Wang X; Moore S; Venere M; Summers MK
Vet Comp Oncol; 2023 Sep; 21(3):492-502. PubMed ID: 37254642
[TBL] [Abstract][Full Text] [Related]
2. Molecular signalling pathways in canine gliomas.
Boudreau CE; York D; Higgins RJ; LeCouteur RA; Dickinson PJ
Vet Comp Oncol; 2017 Mar; 15(1):133-150. PubMed ID: 25808605
[TBL] [Abstract][Full Text] [Related]
3. Inter-pathologist agreement on diagnosis, classification and grading of canine glioma.
Krane GA; Shockley KR; Malarkey DE; Miller AD; Miller CR; Tokarz DA; Jensen HL; Janardhan KS; Breen M; Mariani CL
Vet Comp Oncol; 2022 Dec; 20(4):881-889. PubMed ID: 35856268
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical study of neural stem cell lineage markers in canine brains, gliomas, and a glioma cell line.
Yoshida K; Chambers JK; Uchida K
Vet Pathol; 2023 Jan; 60(1):35-46. PubMed ID: 36384382
[TBL] [Abstract][Full Text] [Related]
5. Epidermal Growth Factor Receptor and Ki-67 Expression in Canine Gliomas.
Fraser AR; Bacci B; le Chevoir MA; Long SN
Vet Pathol; 2016 Nov; 53(6):1131-1137. PubMed ID: 27154542
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical evaluation of tissue factor, fibrin/fibrinogen and D-dimers in canine gliomas.
de la Fuente C; Pumarola M; Blasco E; Fernández F; Viu J; Añor S
Vet J; 2014 Jun; 200(3):387-92. PubMed ID: 24745770
[TBL] [Abstract][Full Text] [Related]
7. A Revised Diagnostic Classification of Canine Glioma: Towards Validation of the Canine Glioma Patient as a Naturally Occurring Preclinical Model for Human Glioma.
Koehler JW; Miller AD; Miller CR; Porter B; Aldape K; Beck J; Brat D; Cornax I; Corps K; Frank C; Giannini C; Horbinski C; Huse JT; O'Sullivan MG; Rissi DR; Mark Simpson R; Woolard K; Shih JH; Mazcko C; Gilbert MR; LeBlanc AK
J Neuropathol Exp Neurol; 2018 Nov; 77(11):1039-1054. PubMed ID: 30239918
[TBL] [Abstract][Full Text] [Related]
8. [Morphological and cytochemical analyses of two in vitro established spontaneous canine brain tumours].
Dahme E; Müller B; Schröder B; Stavrou D
Berl Munch Tierarztl Wochenschr; 1980 Jan; 93(2):21-7. PubMed ID: 7387613
[No Abstract] [Full Text] [Related]
9. Expression and targeting of transcription factor ATF5 in dog gliomas.
York D; Sproul CD; Chikere N; Dickinson PJ; Angelastro JM
Vet Comp Oncol; 2018 Mar; 16(1):102-107. PubMed ID: 28480569
[TBL] [Abstract][Full Text] [Related]
10. In vitro anti-tubulin effects of mebendazole and fenbendazole on canine glioma cells.
Lai SR; Castello SA; Robinson AC; Koehler JW
Vet Comp Oncol; 2017 Dec; 15(4):1445-1454. PubMed ID: 28078780
[TBL] [Abstract][Full Text] [Related]
11. Canine brain tumours: a model for the human disease?
Hicks J; Platt S; Kent M; Haley A
Vet Comp Oncol; 2017 Mar; 15(1):252-272. PubMed ID: 25988678
[TBL] [Abstract][Full Text] [Related]
12. Canine Gliomatosis Cerebri: Morphologic and Immunohistochemical Characterization Is Supportive of Glial Histogenesis.
Rissi DR; Donovan TA; Porter BF; Frank C; Miller AD
Vet Pathol; 2021 Mar; 58(2):293-304. PubMed ID: 33357125
[TBL] [Abstract][Full Text] [Related]
13. Naturally Occurring Canine Glioma as a Model for Novel Therapeutics.
Hubbard ME; Arnold S; Bin Zahid A; McPheeters M; Gerard O'Sullivan M; Tabaran AF; Hunt MA; Pluhar GE
Cancer Invest; 2018; 36(8):415-423. PubMed ID: 30234401
[TBL] [Abstract][Full Text] [Related]
14. Canine intracranial gliomas: relationship between magnetic resonance imaging criteria and tumor type and grade.
Bentley RT; Ober CP; Anderson KL; Feeney DA; Naughton JF; Ohlfest JR; O'Sullivan MG; Miller MA; Constable PD; Pluhar GE
Vet J; 2013 Nov; 198(2):463-71. PubMed ID: 24051197
[TBL] [Abstract][Full Text] [Related]
15. Spontaneously Arising Canine Glioma as a Potential Model for Human Glioma.
Herranz C; Fernández F; Martín-Ibáñez R; Blasco E; Crespo E; De la Fuente C; Añor S; Rabanal RM; Canals JM; Pumarola M
J Comp Pathol; 2016; 154(2-3):169-79. PubMed ID: 26804204
[TBL] [Abstract][Full Text] [Related]
16. The NRG3/ERBB4 signaling cascade as a novel therapeutic target for canine glioma.
Noguchi S; Inoue M; Ichikawa T; Kurozumi K; Matsumoto Y; Nakamoto Y; Akiyoshi H; Kamishina H
Exp Cell Res; 2021 Mar; 400(2):112504. PubMed ID: 33508276
[TBL] [Abstract][Full Text] [Related]
17. Characterization of primary glioma cell lines derived from the patients according to 2016 CNS tumour WHO classification and comparison with their parental tumours.
Oliva MA; Staffieri S; Castaldo S; Giangaspero F; Esposito V; Arcella A
J Neurooncol; 2021 Jan; 151(2):123-133. PubMed ID: 33398536
[TBL] [Abstract][Full Text] [Related]
18. Glioma with cribriform plate involvement in 6 dogs.
Reyes VAA; Howerth EW; Blas-Machado U; Platt SR; Pavarini SP; Castro LT; Church ME; Rissi DR
J Vet Diagn Invest; 2023 Nov; 35(6):800-805. PubMed ID: 37608783
[TBL] [Abstract][Full Text] [Related]
19. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q
BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013
[TBL] [Abstract][Full Text] [Related]
20. Prognostic histopathologic features of canine glial tumors.
Merickel JL; Pluhar GE; Rendahl A; O'Sullivan MG
Vet Pathol; 2021 Sep; 58(5):945-951. PubMed ID: 34219560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
